Acoustic Wave Therapy for ED: Does It Actually Work in 2026?

Low-intensity shockwave therapy (LI-ESWT) produces real, measurable improvements in erectile function for men with mild-to-moderate vasculogenic ED — but the gains are modest, durability past 12 months is uncertain, and the FDA still classifies it as investigational. For most men, it's a credible add-on or escalation option, not a replacement for first-line treatment.

What the Evidence Actually Shows

Multiple meta-analyses confirm that LI-ESWT outperforms sham treatment. A pooled analysis of 16 randomized controlled trials found average IIEF-EF gains of roughly 4 points and an odds ratio of 4.35 for achieving an erection firm enough for penetration compared with placebo [2][12]. Penile Doppler studies back the mechanism: peak systolic velocity increased by about 4 cm/s in treated men, suggesting genuine improvement in arterial inflow [12].

The honest caveat: those gains don't work for everyone. Responses are strongest in men with mild-to-moderate vasculogenic ED — the guy whose problem is early endothelial dysfunction, not severe arterial disease or post-prostatectomy nerve damage. An early sham-controlled RCT showed 57% of active-treatment patients could achieve intercourse without PDE5 inhibitors at five weeks, versus 9% in the sham arm — a striking short-term result — but by 24 weeks that gap had narrowed substantially [8]. Long-term durability remains the therapy's biggest unanswered question.

For context on where this fits against proven options, see our ED medication guide for men over 50 — PDE5 inhibitors like sildenafil and tadalafil still post 60–80% response rates with decades of safety data behind them.

The Device Problem: Not All "Acoustic Wave" Is the Same

This is where the commercial market diverges sharply from the research literature. Published trials use focused extracorporeal shockwave devices at specific energy flux densities — typically around 0.09 mJ/mm² with 1,500–2,000 pulses per site [7]. Many clinics sell "acoustic wave therapy" or "radial wave therapy" using lower-pressure, unfocused devices that have not been tested in rigorous RCTs. The physics are different. The tissue penetration is different. Extrapolating trial results to every clinic advertising a branded protocol is not scientifically justified.

The American Urological Association currently grades LI-ESWT as investigational (evidence level C), and the European Association of Urology offers only a weak recommendation for selected patients [4]. A 2026 SMSNA consensus reinforces that standardized clinical trials are still needed before the therapy earns routine-care status [3]. A full course at a reputable men's health clinic runs $2,400–$6,000 out of pocket, with no insurance coverage [6].

If you're comparing treatment pathways, our breakdown of sildenafil vs. tadalafil is a useful starting point before adding any adjunct therapy.

Who Is a Reasonable Candidate?

The men most likely to benefit are those with documented vasculogenic ED, adequate response to PDE5 inhibitors that has been declining over time, or mild-to-moderate ED where they want to reduce pill dependence. Men with severe arterial disease, psychogenic-primary ED, or post-radical prostatectomy status have weaker evidence supporting the therapy.

Before committing to a four-to-six week protocol at a cash-pay clinic, it's worth discussing the therapy with a provider who can evaluate your penile Doppler, testosterone, and cardiovascular risk profile together. Telehealth platforms covering the full sexual health treatment landscape can be a practical first step for that workup. For men who want a structured evaluation before pursuing device-based therapy, Peter MD offers comprehensive men's sexual health assessments that include baseline labs and treatment sequencing.

An ongoing NIH-registered trial (NCT04434352) is evaluating LI-ESWT across three distinct ED populations [1], which should finally give clinicians the subgroup data needed to match patients to treatment more precisely.

---

Related reading

• Shockwave Therapy vs. Viagra for ED: What the Evidence Actually Shows in 2026

Frequently asked questions

Does acoustic wave therapy permanently fix erectile dysfunction?

Acoustic wave therapy does not reliably produce permanent results based on current evidence. Short-term studies show meaningful improvements in erection quality at three to six months, but data beyond 12 months are sparse, and at least one placebo-controlled trial found the initial advantage over sham had largely disappeared by 24 weeks [8]. Some men do maintain improved function long-term, but predicting who will respond durably isn't yet possible.

How many sessions does acoustic wave therapy for ED require?

Most clinical trial protocols involve six to twelve sessions delivered over four to six weeks, typically two to three sessions per week. Real-world clinic protocols vary considerably, and some providers offer maintenance sessions after the initial course. Because no standardized protocol has been established, the number of sessions — and cost — differs from clinic to clinic [7].

Is acoustic wave therapy for ED covered by insurance?

Acoustic wave therapy for ED is not covered by insurance in the United States as of 2026. The FDA has not approved any shockwave device specifically for ED, and major payers classify it as investigational or experimental [6]. Out-of-pocket costs for a full treatment course typically range from $2,400 to $6,000, depending on provider and location.